PortfoliosLab logoPortfoliosLab logo
BIDU vs. 1093.HK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BIDU vs. 1093.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Baidu, Inc. (BIDU) and CSPC Pharmaceutical Group Ltd (1093.HK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

BIDU is traded in USD, while 1093.HK is traded in HKD. To make them comparable, the 1093.HK values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, BIDU achieves a -11.40% return, which is significantly higher than 1093.HK's -14.70% return. Over the past 10 years, BIDU has underperformed 1093.HK with an annualized return of -3.23%, while 1093.HK has yielded a comparatively higher 17.60% annualized return.


BIDU

1D
-0.29%
1M
-23.08%
YTD
-11.40%
6M
-7.39%
1Y
31.84%
3Y*
-6.71%
5Y*
-9.21%
10Y*
-3.23%

1093.HK

1D
0.43%
1M
-10.12%
YTD
-14.70%
6M
-6.09%
1Y
-18.63%
3Y*
6.07%
5Y*
-7.74%
10Y*
17.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIDU vs. 1093.HK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIDU
Baidu, Inc.
-11.40%54.98%-29.20%4.12%-23.13%-31.19%71.08%-20.30%-32.28%42.45%
1093.HK
CSPC Pharmaceutical Group Ltd
-14.70%81.07%-30.62%-7.78%-0.87%7.97%62.29%69.64%-27.68%93.28%

Correlation

The correlation between BIDU and 1093.HK is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jul 3, 2007

0.16

The correlation between BIDU and 1093.HK shifts across timeframes, from 0.11 (1 year) to 0.24 (3 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIDU vs. 1093.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIDU
BIDU Risk / Return Rank: 6262
Overall Rank
BIDU Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
BIDU Sortino Ratio Rank: 6363
Sortino Ratio Rank
BIDU Omega Ratio Rank: 6060
Omega Ratio Rank
BIDU Calmar Ratio Rank: 6363
Calmar Ratio Rank
BIDU Martin Ratio Rank: 6262
Martin Ratio Rank

1093.HK
1093.HK Risk / Return Rank: 2626
Overall Rank
1093.HK Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
1093.HK Sortino Ratio Rank: 2626
Sortino Ratio Rank
1093.HK Omega Ratio Rank: 2727
Omega Ratio Rank
1093.HK Calmar Ratio Rank: 2525
Calmar Ratio Rank
1093.HK Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIDU vs. 1093.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Baidu, Inc. (BIDU) and CSPC Pharmaceutical Group Ltd (1093.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BIDU1093.HKDifference
Sharpe ratioReturn per unit of total volatility

+1.01

Sortino ratioReturn per unit of downside risk

+1.53

Omega ratioGain probability vs. loss probability

1.15

0.97

+0.18

Calmar ratioReturn relative to maximum drawdown

0.93

-0.49

+1.42

Martin ratioReturn relative to average drawdown

2.00

-0.88

+2.88

BIDU vs. 1093.HK - Sharpe Ratio Comparison

The current BIDU Sharpe Ratio is 0.63, which is higher than the 1093.HK Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of BIDU and 1093.HK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BIDU vs. 1093.HK - Drawdown Comparison

The maximum BIDU drawdown since its inception was -77.47%, roughly equal to the maximum 1093.HK drawdown of -74.75%. Use the drawdown chart below to compare losses from any high point for BIDU and 1093.HK.


Loading charts...

Drawdown Indicators


BIDU1093.HKDifference

Max Drawdown

Largest peak-to-trough decline

-77.47%

-74.75%

-2.72%

Max Drawdown (1Y)

Largest decline over 1 year

-34.41%

-38.76%

+4.35%

Max Drawdown (3Y)

Largest decline over 3 years

-50.73%

-38.76%

-11.97%

Max Drawdown (5Y)

Largest decline over 5 years

-63.13%

-60.80%

-2.33%

Max Drawdown (10Y)

Largest decline over 10 years

-77.47%

-61.22%

-16.25%

Current Drawdown

Current decline from peak

-65.94%

-36.31%

-29.63%

Average Drawdown

Average peak-to-trough decline

-35.56%

-26.99%

-8.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.96%

21.40%

-5.44%

Volatility

BIDU vs. 1093.HK - Volatility Comparison

Baidu, Inc. (BIDU) has a higher volatility of 14.89% compared to CSPC Pharmaceutical Group Ltd (1093.HK) at 13.42%. This indicates that BIDU's price experiences larger fluctuations and is considered to be riskier than 1093.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIDU1093.HKDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.89%

13.42%

+1.47%

Volatility (6M)

Calculated over the trailing 6-month period

35.91%

35.29%

+0.62%

Volatility (1Y)

Calculated over the trailing 1-year period

50.52%

50.50%

+0.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.93%

44.77%

+7.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.30%

47.12%

-0.82%

Dividends

BIDU vs. 1093.HK - Dividend Comparison

BIDU has not paid dividends to shareholders, while 1093.HK's dividend yield for the trailing twelve months is around 1.93%.


PositionTTM20252024202320222021202020192018201720162015
1093.HK
CSPC Pharmaceutical Group Ltd
1.93%2.85%6.28%3.44%2.44%2.01%1.79%1.86%2.55%1.46%2.55%2.43%
BIDU
Baidu, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BIDU vs. 1093.HK - Financials Comparison

This section allows you to compare key financial metrics between Baidu, Inc. and CSPC Pharmaceutical Group Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. BIDU values in CNY, 1093.HK values in HKD

Frequently Asked Questions


BIDU and 1093.HK have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for BIDU and 1093.HK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer